Ryanodine receptor phosphorylation by oxidized CaMKII contributes to the cardiotoxic effects of cardiac glycosides

HT Ho, B Liu, JS Snyder, Q Lou… - Cardiovascular …, 2014 - academic.oup.com
Aims Recent studies suggest that proarrhythmic effects of cardiac glycosides (CGs) on
cardiomyocyte Ca2+ handling involve generation of reactive oxygen species (ROS) …

A perspective on re‐evaluating digoxin's role in the current management of patients with chronic systolic heart failure: targeting serum concentration to reduce …

KF Adams Jr, JK Ghali… - European journal of …, 2014 - Wiley Online Library
Digoxin improves exercise tolerance and reduces hospitalizations in patients with systolic
heart failure, but its use has declined progressively for the past two decades. The Digitalis …

Low-dose cardiotonic steroids increase sodium–potassium ATPase activity that protects hippocampal slice cultures from experimental ischemia

M Oselkin, D Tian, PJ Bergold - Neuroscience letters, 2010 - Elsevier
The sodium–potassium ATPase (Na/K ATPase) is a major ionic transporter in the brain and
is responsible for the maintenance of the Na+ and K+ gradients across the cell membrane …

Pharmacokinetics of the direct factor Xa inhibitor edoxaban and digoxin administered alone and in combination

J Mendell, RJ Noveck, M Shi - Journal of cardiovascular …, 2022 - journals.lww.com
The oral anticoagulant edoxaban, a factor Xa inhibitor, will likely be coadministered with
digoxin in some patients with atrial fibrillation. Both drugs are substrates for P–glycoprotein …

In vivo rescue of genetic dilated cardiomyopathy by systemic delivery of nexilin

Y Shao, C Liu, HK Liao, R Zhang, B Yuan, H Yang, R Li… - Genome Biology, 2024 - Springer
Background Dilated cardiomyopathy (DCM) is one of the most common causes of heart
failure. Multiple identified mutations in nexilin (NEXN) have been suggested to be linked …

Digoxin therapy and associated clinical outcomes in the MADIT-CRT trial

AY Lee, V Kutyifa, MH Ruwald, S McNitt, B Polonsky… - Heart Rhythm, 2015 - Elsevier
Background Digoxin's pharmacological, hemodynamic, and electrophysiological properties
are well understood. However, in modern heart failure (HF) treatment, its effect has yet to be …

Targeting host cell proteases as a potential treatment strategy to limit the spread of SARS‐CoV‐2 in the respiratory tract

IA El‐Shimy, MMA Mohamed… - Pharmacology …, 2021 - Wiley Online Library
As the death toll of Coronavirus disease 19 (COVID‐19) continues to rise worldwide, it is
imperative to explore novel molecular mechanisms for targeting SARS‐CoV‐2. Rather than …

The role of cardiotonic steroids in the pathogenesis of cardiomyopathy in chronic kidney disease

D Pavlovic - Nephron Clinical Practice, 2014 - karger.com
Cardiotonic steroids (CTS) are a new class of hormones that circulate in the blood and are
divided into two distinct groups, cardenolides, such as ouabain and digoxin, and …

The crystal structure of progesterone 5β-reductase from Digitalis lanata defines a novel class of short chain dehydrogenases/reductases

A Thorn, C Egerer-Sieber, CM Jäger, V Herl… - Journal of Biological …, 2008 - ASBMB
Progesterone 5β-reductase (5β-POR) catalyzes the stereospecific reduction of progesterone
to 5β-pregnane-3, 20-dione and is a key enzyme in the biosynthetic pathway of …

Arrhythmogenic adverse effects of cardiac glycosides are mediated by redox modification of ryanodine receptors

HT Ho, SCW Stevens, R Terentyeva… - The Journal of …, 2011 - Wiley Online Library
Non‐Technical Summary Cardiac glycosides (CGs) have been routinely used in the
treatment of congestive heart failure (HF). Unfortunately, the therapeutic use of CGs in …